T-TIME Alternatives: Enclomiphene Providers Compared (2026)
- Medication: Oral enclomiphene citrate
- Pricing: From $69/mo; $207 per 90-day supply, renewing every 85 days ($99 for a 30-day supply)
- Labs: Extra: $49 Quest (not in NY, NH, CT or NJ) or $79 at-home; recent labs accepted
- Prescriber: Licensed M.D.
- Availability: US only; no state list published
- Process: Faster start process; 100% online
Our verdict: T-TIME is our top pick for most men starting enclomiphene online. It has the lowest published price we track ($69/mo), a licensed M.D. prescribes, and the whole process is online with home delivery.
Who provides the care: T-TIME runs its medical care through Beluga Health, whose licensed clinicians review each patient's health information and prescribe only when treatment is medically appropriate. Prescriptions are filled by independent, licensed U.S. pharmacies, including Curexa in New Jersey and EPIQ Scripts in Texas, and T-TIME names these partners publicly with links to their licenses and accreditations. See T-TIME's care and pharmacy partners ↗
From $69/mo
We may earn a commission if you sign up through our links. Your price is the same. How we work
The short version
Looking for T-TIME alternatives? Here are the main U.S. enclomiphene providers we track - how they differ on price, onboarding, and clinician model - so you can choose on fit and total cost rather than ad spend.
If you're searching 'T-TIME alternatives,' you've already done the smart thing: you're comparing rather than clicking the first ad. T-TIME sits at the low end of published enclomiphene anchors (~$69/mo), but price is only one factor. Here are the main providers we track and how they tend to differ.
The main enclomiphene alternatives
- Hims - a large, well-known telehealth brand with a higher published anchor (~$99/mo) and a broad consumer funnel.
- Maximus Tribe - a men's optimization brand that markets enclomiphene alongside a performance-oriented positioning.
- Hone Health - a labs-forward model with a higher anchor, emphasizing testing and clinician review.
- Joi + Blokes, PeterMD, Defy Medical, ConciergeMD - additional clinician or clinic-style options with varying onboarding and pricing.
- T-TIME itself - lowest published anchor and a 'faster start' onboarding label.
How to choose between them
Decide on three axes: total 90-day cost (medication plus labs, shipping, and fees), clinician access and lab cadence, and how the onboarding fits your life. The cheapest anchor is not automatically the best value, and the most expensive is not automatically the most thorough - match the model to your needs and your labs.
See direct head-to-heads: Hims vs T-TIME, Maximus Tribe vs T-TIME, and Hone Health vs T-TIME. For a three-way overview, read choosing between T-TIME, Hims and Hone Health.
T-TIME · From $69/mo
Where T-TIME tends to win - and where it might not
T-TIME's strength is its low published anchor and streamlined start. If you prioritize a labs-heavy or high-touch concierge experience, a higher-priced alternative may fit better. Start from the T-TIME provider page and the full enclomiphene providers list to compare on your own terms.
Where to go next: Read our full T-TIME review, or read our profile of T-TIME founder Moshe Saraf.
FAQ
What is the cheapest enclomiphene provider?
Among the brands we track, T-TIME has the lowest published monthly anchor (~$69/mo). Your real cost still depends on labs, shipping, and plan length, so compare 90-day totals before deciding.
Is there a better alternative to T-TIME?
'Better' depends on what you value. If you want the lowest anchor and a fast start, T-TIME is competitive; if you want a labs-forward or concierge model, providers like Hone Health or clinic-style options may suit you more. Compare on fit, not just price.
Can I switch providers later?
Generally yes, but bring your prior labs and current prescription details to any new clinician so therapy continuity and safety are preserved. Review cancellation terms with your current provider first.
T-TIME · From $69/mo
T-TIME: pros and cons
Pros
- Lowest published price we track: $69/mo on the 90-day plan ($207 per supply)
- Licensed M.D. reviews every case and prescribes
- Fully online, with medication shipped to your door
- Recent lab results accepted, which can save a new lab draw
Cons
- Labs cost extra ($49 at Quest or $79 at home)
- $69/mo needs the 90-day plan, which renews every 85 days (about 5 charges a year); the 30-day plan is $99
Our verdict: T-TIME is our top pick for most men starting enclomiphene online. It has the lowest published price we track ($69/mo), a licensed M.D. prescribes, and the whole process is online with home delivery.
T-TIME · From $69/mo
Other T-TIME treatments, including GLP-1
T-TIME is not only an enclomiphene provider. The same online intake and clinician team also covers these treatments, with GLP-1 weight-loss care the best known:
- GLP-1 weight loss
Compounded semaglutide (as tablets or injections) and tirzepatide, with clinician-guided dosing and flat plan prices.
- Sermorelin
An oral option aimed at sleep, recovery and daily energy.
- LDN (low dose naltrexone)
An oral option aimed at inflammation, everyday pain and brain fog.
- OVERTIME
An ED treatment: troches that combine vardenafil and tadalafil.
- Charge
A daily chew that pairs enclomiphene with tadalafil.
For GLP-1 prices and terms, read our T-TIME GLP-1 review or compare six programs in our GLP-1 guide for men.
Each treatment needs its own clinician review. Check eligibility and prices on T-TIME's site.
What the research says
In two 16-week phase III trials, enclomiphene raised testosterone and kept sperm counts in the normal range, while testosterone gel markedly reduced sperm production.
Overweight men aged 18-60 with secondary hypogonadism.
Kim et al., BJU International, 2016 ↗Enclomiphene is not sold as its own FDA-approved drug; it is one of the two parts of clomiphene (Clomid). Online programs supply it through compounding pharmacies, so ask how yours is made and tested.
FDA status as of its June 2022 compounding committee review.
FDA briefing document, 2022 ↗
Sources and further reading
Primary references behind this topic: agency pages, clinical guidelines and published trials. Education only, not a substitute for your clinician's judgment.
- MedlinePlus (NIH): Clomiphene drug information
Official patient information on clomiphene (Clomid), the parent drug of enclomiphene.
- Krzastek et al., Journal of Urology 2019
Long-term clomiphene citrate was effective with few side effects in men treated for hypogonadism.
- Kim et al., BJU International 2016 (two phase III trials)
Enclomiphene raised testosterone while keeping sperm counts in the normal range; testosterone gel lowered sperm counts.
- American Urological Association: Testosterone Deficiency Guideline
Diagnosis needs symptoms plus two early-morning total testosterone tests below about 300 ng/dL.
You might also like
More articles on T-Compare, plus quick links to our comparison tools.
- How T-TIME Cut Enclomiphene Costs in Half for American Men
While enclomiphene draws attention across the U.S., T-TIME describes a simpler path to treatment and lower pricing than many comparable services-in their own words, below. Informational only; verify details with T-TIME or your clinician.
Read article → - Is T-TIME FDA Approved? Enclomiphene and Compounding Explained
Is T-TIME FDA approved? It is a fair question with a nuanced answer. Here is a plain-English explanation of enclomiphene's regulatory status, what compounding means, and why 'FDA approved' is the wrong yes/no question for this category.
Read article → - T-TIME for Fatigue, Low Libido, and Low Energy: Does It Fit?
Considering T-TIME because you're tired, flat, or noticing low libido? Those symptoms have many causes. Here is how to think about whether an enclomiphene program fits your situation - and why labs, not symptoms alone, should drive the decision.
Read article → - T-TIME on Reddit: What People Actually Say (and How to Read It)
Looking up 'T-TIME Reddit'? Forum threads can be useful for vibes and red flags but terrible for medical decisions. Here is how to read community sentiment about enclomiphene programs without letting anecdotes set your treatment.
Read article →